Clinical impact of low-burden BCR-ABL1 mutations detectable by amplicon deep sequencing in Philadelphia-positive acute lymphoblastic leukemia patients.
about
Clinical impact of low-burden BCR-ABL1 mutations detectable by amplicon deep sequencing in Philadelphia-positive acute lymphoblastic leukemia patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Clinical impact of low-burden ...... mphoblastic leukemia patients.
@en
Clinical impact of low-burden ...... mphoblastic leukemia patients.
@nl
type
label
Clinical impact of low-burden ...... mphoblastic leukemia patients.
@en
Clinical impact of low-burden ...... mphoblastic leukemia patients.
@nl
prefLabel
Clinical impact of low-burden ...... mphoblastic leukemia patients.
@en
Clinical impact of low-burden ...... mphoblastic leukemia patients.
@nl
P2093
P2860
P50
P356
P1433
P1476
Clinical impact of low-burden ...... ymphoblastic leukemia patients
@en
P2093
A Kohlmann
C De Benedittis
G Martinelli
K Machova Polakova
M Baccarani
P2860
P2888
P304
P356
10.1038/LEU.2016.17
P577
2016-02-12T00:00:00Z